States Take Varied Approaches to Rx Benefits in Medicaid
February
22
NOTES: Nevada plans to carve out the prescription drug benefit effective in FY 2023, when MCO contracts are renewed. California and New York plan to carve out pharmacy benefits starting in April 2021. Utah did not respond to the survey. Michigan reported it carves out select oncology drugs but not the entire class.
SOURCES: 2019 KFF and Health Management Associates survey of Medicaid officials in 50 states and DC, Kaiser Family Foundation. Visit https://bit.ly/3sZGDtG. “State Medicaid Programs Respond to Meet COVID-19 Challenges: Results from a 50-State Medicaid Budget Survey for State Fiscal Years 2020 and 2021,” visit https://bit.ly/3t0HpXl.
Related Posts
September
21
McClellan: IRA Price Negotiations May Have Broader Impact Beyond Drugs on List
Read More
September
21
FDA Approves First Multiple Sclerosis Biosimilar, Sandoz’s Tyruko
Read More
September
21
Now That Humira Biosimilars Have Launched, What Are Lessons Learned for Stelara Biosimilars?
Read More
Meet Our Reporters
-
Lauren Flynn Kelly Executive Editor, AIS Health, and Managing Editor, Radar on Medicare Advantage
View Lauren Flynn Kelly's Profile -
Angela Maas Managing Editor, Radar on Specialty Pharmacy and Spotlight on Market Access
View Angela Maas's Profile -
Leslie Small Managing Editor, Health Plan Weekly and Radar on Drug Benefits
View Leslie Small's Profile -
Peter Johnson Reporter, Health Plan Weekly and Radar on Drug Benefits
View Peter Johnson's Profile -
Tim Casey Reporter, Health Plan Weekly and Radar on Drug Benefits
View Tim Casey's Profile -
Carina Belles Reporter, Radar on Medicare Advantage and Spotlight on Market Access
View Carina Belles's Profile -
Jinghong Chen Reporter, Health Plan Weekly and Radar on Drug Benefits
View Jinghong Chen's Profile